WHO chief thanks PM Modi for 'continued support' to global Covid response

WHO Director-General Tedros Adhanom Ghebreyesus. Photo: Bloomberg

WHO chief Tedros Adhanom Ghebreyesus on Saturday thanked Prime Minister Narendra Modi for his continued support to the global COVID-19 response, saying acting together, including sharing of knowledge, will help in combating the novel coronavirus that has claimed over 2 million lives and infected more than 96 million people across the world.

India this week announced that it will send COVID-19 vaccines under grant assistance to Sri Lanka and seven other countries - Bhutan, the Maldives, Bangladesh, Nepal, Myanmar, Seychelles, Afghanistan and Mauritius.

Nepal, Bangladesh, Bhutan and the Maldives have already received India's COVID-19 vaccines under grant assistance in sync with its "Neighbourhood First policy.

"Thank you, India and Prime Minister Narendra Modi for your continued support to global Covid-19 response. Only if we act together, including sharing of knowledge, can we stop this virus and save lives and livelihoods," tweeted Ghebreyesus, the Director-General of World Health Organization.

Prime Minister Modi has said India's vaccine production and delivery capacity will be used for the benefit of all humanity to fight the COVID-19 pandemic.

He said last week India was ready to do everything possible for a healthy planet.

On January 19, India announced its grant assistance of vaccines to the neighbouring countries. A day after, 1.5 lakh doses of vaccines were supplied to Bhutan and one lakh doses to the Maldives as grant assistance. Over 2 million doses of COVID-19 vaccines were provided to Bangladesh and 1 million doses to Nepal.

India, one of the world's biggest drugmakers, has already rolled out a massive coronavirus vaccination drive using two vaccines, Covishield and Covaxin.

Covishield has been developed by AstraZeneca and Oxford University and is being manufactured by Serum Institute of India. Covaxin is an indigenous vaccine developed by Bharat Biotech in collaboration with Indian Council of Medical Research.

India on Friday began commercial exports and sent two million doses of domestically manufactured Covishield vaccine to Brazil.

India has undertaken contractual supplies of coronavirus vaccines to Saudi Arabia, South Africa, Brazil, Morocco, Bangladesh and Myanmar, the Ministry of External Affairs said in New Delhi on Friday.

Several countries have already approached India for procuring the coronavirus vaccines.

Earlier, India had supplied hydroxychloroquine, Remdesivir and paracetamol tablets, as well as diagnostic kits, ventilators, masks, gloves and other medical supplies to a large number of countries to help them deal with the pandemic.

According to Johns Hopkins University, the current global COVID-19 caseload and death toll stood at 98,129,394 and 2,105,056, respectively.


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel